| (210) | Number of the EPO application | 18779167 |
| (220) | Filing date of the EPO application | 2018.09.10 |
| (80) | EPO patent specification publication (B) | EPB nr. 20/2022, 2022.05.18 |
| (110) | EPO patent number | 3681483 |
| (21) | Number of the application | e 2020 0740 |
| (71) | Name(s) of applicant(s), code of the country | AMGEN INC., US; |
| (72) | Name(s) of inventor(s), code of the country | TALLEY Clea, US; |
| (73) | Name(s) of owner(s), code of the country | AMGEN INC., US; |
| (54) | Title of the invention | PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEIN |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/19 (2006.01.01); A61K 47/10 (2017.01.01); A61K 47/26 (2006.01.01); A61K 47/18 (2017.01.01); A61K 38/19 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.08.31 |
| (30) | Priority | 201762559420 P, 2017.09.15, US |
| (86) | International application | PCT/US2018/050305, 2018.09.10 |
| (87) | International publication | WO 2019/055357, 2019.03.21 |